PCG
BNTX icon

Private Capital Group’s BioNTech BNTX Stock Holding History

Private Capital Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$5K Sell
34
-28
-45% -$4.28K ﹤0.01% 1236
2022
Q1 		$11K Buy
62
+19
+44% +$3.19K ﹤0.01% 1233
2021
Q4 		$11K Buy
+43
New +$11.8K ﹤0.01% 1252

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Private Capital Group's BNTX Position: Q2 2022 in Review

Private Capital Group reduced its BioNTech (BNTX) stake by 45% in Q2 2022, selling an estimated $4.28K and leaving 34 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Private Capital Group first reported a position in BNTX in Q4 2021 and has held it in 3 quarters since. The position peaked at $11K in Q1 2022. 292 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Private Capital Group held 34 shares of BioNTech worth $5K as of Q2 2022.
  • Private Capital Group sold 28 BioNTech shares in Q2 2022, an estimated $4.28K.
  • BioNTech made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1236 holding.
  • Private Capital Group first reported a position in BioNTech in Q4 2021 and has held it in 3 quarters since.
  • Private Capital Group's BioNTech position peaked at $11K in Q1 2022.
  • 292 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.